Dr. Blitzer is an assistant professor in the Department of Human Oncology at the University of Wisconsin. She serves as the primary radiation oncologist at the UW Cancer Center in Johnson Creek, where she treats all types of cancer in adults. The UW Cancer Center Johnson Creek has a state-of-the-art linear accelerator that is the same as the machines at UW Carbone Cancer Center, which allows me to treat cancer using the same advanced techniques available to UWCCC.
Faculty
Paul Sondel, MD, PhD
I am the Reed and Carolee Walker Professor of Pediatric Oncology. I grew up in Milwaukee and earned undergraduate and doctoral degrees in genetics at the University of Wisconsin–Madison with guidance from bone marrow transplant pioneer Dr. Fritz Bach. I received my medical degree magna cum laude in 1977 from Harvard Medical School, where I began my research in tumor immunology. Following pediatric residencies in at the University of Minnesota and the University of Wisconsin, I joined the UW faculty in 1980 in the Departments of Pediatrics, Human Oncology and Genetics.
Steven Howard, MD, PhD
Dr. Steven Howard has expertise in the treatment of patients with brain tumors. His research focuses on the clinical application of new radiation techniques and radiation-drug combinations to improve outcomes for brain tumor patients. Dr. Howard has received numerous awards and honors for his work in Radiation Oncology.
Adam Bayliss, PhD
I am an assistant professor in the Department of Human Oncology, where I apply my skills as a physicist and research scientist to the study of physics in medicine and daily clinical practice. I assess the available literature, test and safely implement new modalities and provide quality assurance of existing techniques and equipment.
Jessica Schuster, MD
Dr. Jessica Schuster ism a clinical associate professor in the Department of Human Oncology and serves as the primary radiation oncologist at UW Cancer Center Johnson Creek, where she treats all adult cancer sites. She has a particular interest in using radiation to treat breast, prostate and lung cancers and benign diseases such as Dupuytren’s contracture. She also focuses on palliative care and symptom management.
Randal Tibbetts, PhD
Current work in the Tibbetts lab is aimed at understanding how diverse growth-inhibitory signals, including DNA damage, cell-cell contact and growth factor depletion downregulate gene expression through the CREB pathway and how defects in this regulation contribute to tumorigenesis. It is also deciphering how alternative splicing influences DNA damage repair and tumor suppression using cellular and in vivo (mouse) models. The laboratory has developed several Drosophila melanogaster (fruit fly) models for the motor neuron disease amyotrophic lateral sclerosis.
Kristin Bradley, MD
Dr. Bradley participates in clinical research, evaluating ways to improve cancer care in patients with gynecologic, hematologic or pediatric cancers who are receiving radiation as a component of their treatment. In addition to her clinical practice, she is the Radiation Oncology Residency Program director. She is also involved with teaching medical students and undergraduates.
Dinesh Tewatia, PhD
In my current role as an associate professor in the Department of Human Oncology, I strive to apply knowledge and expertise from several interdisciplinary fields to better serve cancer patients. I feel privileged to be part of a large and talented team of physicists and physicians here at UW Madison and to have the opportunity to serve at the main campus and also at UW Cancer Center–Johnson Creek.
Paul Harari, MD
Dr. Paul Harari is chairman of the Department of Human Oncology, principal investigator for the Wisconsin H&N SPORE Grant and member of the UW Carbone Cancer Center Senior Leadership Council. His clinical and laboratory research is focused on improving treatment outcomes for patients with head and neck cancer.
Michael Bassetti, MD, PhD
Dr. Bassetti is an associate professor in the Department of Human Oncology with a clinical focus on gastrointestinal cancers and research interests in MRI-guided radiation and immunotherapy. He has been developing the use of real-time MRI-guided radiation to reduce toxicity, maximize local control and improve patient outcomes. Additionally, he is involved in combining immunotherapies with anatomically targeted high-dose radiotherapy to improve the antigen specific T cell response.